Nano Medicevo Announces Broad Reimbursement Approval in China for NanoPrecision(TM) Digital Laparoscopy System
Reimbursement decision provides expanded access to NanoPrecision™ Digital Laparoscopy for patients, surgeons, and hospitals across China.
Nano Medicevo (ISIN: JP3630033300), a privately-held medical company that offers products and services to advance the entire medical treatment process from diagnosis to post treatment care, is pleased to announce that China’s Health authorities expert review panel provided reimbursement for procedures performed with the NanoPrecision™ Robotic Surgi..
Comments Off on Nano Medicevo Announces Broad Reimbursement Approval in China for NanoPrecision(TM) Digital Laparoscopy System